WebMar 3, 2024 · Dyne Therapeutics, Inc. WALTHAM, Mass., March 03, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming ... WebIndependent Director, Dyne Therapeutics, Inc. Dirk Kersten occupies the position of General Partner of Forbion Capital Partners Management Holding BV. Mr. Kersten is also on the board of Dyne ...
Dyne Therapeutics Series B financing - CureDuchenne
WebApr 11, 2024 · As a Managing Director at Vida, Stefan serves on the Board of Directors for Vigil Neuroscience (“VIGL”), Tectonic Therapeutic, Volastra Therapeutics, and Souffle Therapeutics. He was previously a Board Director or Observer at Praxis Precision Medicines (“PRAX”), Kyverna Therapeutics, Oyster Point Therapeutics (“OYST”), Dyne ... WebMar 3, 2024 · Dyne Therapeutics Appoints Carlo Incerti, M.D., to its Board of Directors. March 03, 2024 07:30 ET Source: Dyne Therapeutics, Inc. WALTHAM, Mass., March … smarsh annual revenue
DYNE THERAPEUTICS, INC. NOMINATING AND CORPORATE …
WebMar 3, 2024 · WALTHAM, Mass., March 03, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors. Dr. … WebCAMBRIDGE, Mass.– Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of Catherine Stehman-Breen, M.D., to its Board of Directors. “This is an exciting time at Dyne as we advance our platform of targeted therapies for patients with serious muscle ... WebApr 23, 2024 · “We are pleased to welcome David to the Board. He is a seasoned life sciences leader with experience spanning strategy, finance, capital markets, M&A and … hilfe pecs